User profiles for D. Lambrechts

Diether Lambrechts

Laboratory for Translational Genetics, Department of Oncology, VIB and KULeuven, Leuven …
Verified email at vib-kuleuven.be
Cited by 64295

VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection

E Storkebaum, D Lambrechts, P Carmeliet - Bioessays, 2004 - Wiley Online Library
Both blood vessels and nerves are guided to their target. Vascular endothelial growth factor
(VEGF)A is a key signal in the induction of vessel growth (a process termed angiogenesis). …

Role and therapeutic potential of VEGF in the nervous system

C Ruiz de Almodovar, D Lambrechts… - Physiological …, 2009 - journals.physiology.org
… (156); the role of endogenous VEGF-D, even though capable of … No role for VEGF-D in the
nervous system is known thus far. … Likewise, VEGF-C and -D are known to bind heterodimers …

Markers of response for the antiangiogenic agent bevacizumab

D Lambrechts, HJ Lenz, S de Haas… - Journal of Clinical …, 2013 - ascopubs.org
Bevacizumab is the first antiangiogenic therapy proven to slow metastatic disease progression
in patients with cancer. Although it has changed clinical practice, some patients do not …

[HTML][HTML] Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

…, A Ziegler, I Buysschaert, D Lambrechts… - The Lancet, 2012 - thelancet.com
Background High plasma HDL cholesterol is associated with reduced risk of myocardial
infarction, but whether this association is causal is unclear. Exploiting the fact that genotypes are …

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

…, G Kolovou, A Kong, R Laaksonen, D Lambrechts… - Nature …, 2011 - nature.com
We performed a meta-analysis of 14 genome-wide association studies of coronary artery
disease (CAD) comprising 22,233 individuals with CAD (cases) and 64,762 controls of …

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a …

…, E Van Cutsem, H Piessevaux, D Lambrechts… - The lancet …, 2010 - thelancet.com
… (D) Kaplan-Meier estimates of the overall survival time (in weeks) are shown in the terminal
nodes. The tree shows that to best predict overall survival, KRAS mutations should be …

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

…, X Wang, C Vachon, KN Stevens, D Lambrechts… - Nature …, 2013 - nature.com
Breast cancer is the most common cancer among women. Common variants at 27 loci have
been identified as associated with susceptibility to breast cancer, and these account for ∼9…

[HTML][HTML] Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 …

…, J Bridgewater, MJ Kennedy, B Claes, D Lambrechts… - The Lancet, 2011 - thelancet.com
Background In the Medical Research Council (MRC) COIN trial, the epidermal growth factor
receptor (EGFR)-targeted antibody cetuximab was added to standard chemotherapy in first-…

Role of PlGF in the intra-and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

…, D Communi, A Kranz, L Moons, D Lambrechts… - Nature medicine, 2003 - nature.com
… To document whether a combination of PGF and VEGF would be more potent in stimulating
postischemic angiogenesis in vivo, we administered these ligands for 7 d after coronary …

Phenotype molding of stromal cells in the lung tumor microenvironment

D Lambrechts, E Wauters, B Boeckx, S Aibar… - Nature medicine, 2018 - nature.com
Cancer cells are embedded in the tumor microenvironment (TME), a complex ecosystem of
stromal cells. Here, we present a 52,698-cell catalog of the TME transcriptome in human lung …